The Defense Health Agency awarded The Wistar Institute of Anatomy and Biology $1.05 million on November 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to investigate metabolic control of immune cold CCNE1-driven ovarian cancers. Performance occurs in Philadelphia, Pennsylvania, with work concluding October 31, 2029.